List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 255 studies with search of: lupus
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
2 Recruiting HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Education
3 Recruiting Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: Abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
4 Recruiting Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
5 Recruiting Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Depomedrol;   Other: Blood drawing only;   Drug: Methotrexate and depomedrol;   Drug: Mycophenolate mofetil and depomedrol
6 Completed Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
Conditions: Immunologic Diseases;   Autoimmune Diseases;   Systemic Lupus Erythematosus;   Lupus Nephritis;   Lupus Glomerulonephritis
Intervention: Drug: Abetimus sodium (LJP 394)
7 Recruiting Lupus Genetics Studies
Condition: Systemic Lupus Erythematosus
Intervention:
8 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: cyclophosphamide
9 Recruiting Duke Lupus Registry
Conditions: Systemic Lupus Erythematosus;   Cutaneous Lupus
Intervention:
10 Completed Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Condition: Systemic Lupus Erythematosus
Intervention:
11 Completed Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
Conditions: Glomerulonephritis;   Lupus Nephritis;   Systemic Lupus Erythematosus
Intervention: Drug: SQ Fludarabine
12 Terminated Etanercept for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Etanercept;   Drug: Lupus Treatment
13 Completed Anti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: Rituximab
14 Completed Study of Methotrexate in Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Methotrexate and folic acid
15 Terminated Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition: Discoid Lupus Erthematosus of the Scalp.
Intervention: Drug: Raptiva (efalizumab)
16 Completed Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study
Conditions: Systemic Lupus Erythematosus;   Lupus Nephritis
Interventions: Drug: Cyclosporine A;   Drug: Cyclophosphamide
17 Recruiting Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Condition: Refractory Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic MSC (AlloMSC)
18 Not yet recruiting The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: mycophenolate sodium;   Drug: cyclophosphamide
19 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
20 Terminated TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: infliximab;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services